Anti-SARS-CoV-2 seroprevalence in King County, WA-Cross-sectional survey, August 2020

被引:2
|
作者
Cowgill, Karen D. [1 ]
Erosheva, Elena A. [2 ,3 ]
Elder, Adam [4 ]
Miljacic, Ljubomir [5 ]
Buskin, Susan [6 ,7 ]
Duchin, Jeffrey S. [6 ,7 ,8 ]
机构
[1] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA
[2] Univ Washington, Sch Social Work, Dept Stat, Seattle, WA 98195 USA
[3] Univ Washington, Ctr Stat & Social Sci, Seattle, WA 98195 USA
[4] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA
[5] Mt Whisper Light, Seattle, WA USA
[6] Publ Hlth Seattle & King Cty, Seattle, WA USA
[7] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA
[8] Univ Washington, Sch Med, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA
来源
PLOS ONE | 2022年 / 17卷 / 08期
关键词
D O I
10.1371/journal.pone.0272783
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We conducted a seroprevalence survey to estimate the true number of infections with SARS-CoV-2, the virus that causes COVID-19, in King County as of August 2020 by measuring the proportion of residents from who had antibodies against the virus. Participants from 727 households took part in a cross-sectional address-based household survey with random and non-random samples and provided dried blood spots that were tested for total antibody against the viral nucleocapsid protein, with confirmatory testing for immunoglobulin G against the spike protein. The data were weighted to match King County's population based on sex, age group, income, race, and Hispanic status. After weighting and accounting for the accuracy of the tests, our best overall estimate of anti-SARS-CoV-2 seroprevalence in King County as of August 2020 is 3.9% (95% confidence interval (CI) 2.4%-6.0%) with an effective sample size of 589. Comparing seroprevalence with positive test reports, our survey suggests that viral testing underestimated incidence by a factor of about five and suggests that the proportion of cases that were serious (based on hospitalization) or fatal was 2.4% and 0.8%, respectively. Prevalence varied by subgroup; households reporting incomes at or below $100,000 in 2019 had nearly five times higher estimated antibody prevalence than those with incomes above $100,000. Those reporting non-White/non-Asian race had roughly seven times higher estimated antibody prevalence than those reporting White race. This survey was noteworthy for including people of all ages; among all age groups, the weighted estimate of prevalence was highest in older teens and young adults and lowest in young children, although these differences were not statistically significant.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: a community-based cross-sectional study, August 2020
    Sakalle, Salil
    Saroshe, Satish
    Shukla, Harish
    Mutha, Anita
    Vaze, Ameya
    Arora, Arpit
    Athotra, Aditya
    Ramaswamy, Sudarshan
    Jain, Arania
    Dhuria, Meera
    Patil, Anil D.
    Rai, Arvind
    Garg, Suneela
    Jain, Sudhir K.
    Bindal, Jyoti
    Singh, Sujeet K.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (03) : 1479 - 1484
  • [2] Seroprevalence of anti-SARS-CoV-2 antibodies in Senegal: a national population-based cross-sectional survey, between October and November 2020
    Talla, Cheikh
    Loucoubar, Cheikh
    Roka, Jerlie Loko
    Barry, Mamadou A.
    Ndiaye, Seynabou
    Diarra, Maryam
    Thiam, Mareme Seye
    Faye, Oumar
    Dia, Moussa
    Diop, Mamadou
    Ndiaye, Oumar
    Tall, Adama
    Faye, Rokhaya
    Mbow, Adji Astou
    Diouf, Babacar
    Diallo, Jean Pierre
    Keita, Ibrahima Mamby
    Ndiaye, Mamadou
    Woudenberg, Tom
    White, Michael
    Ting, Jim
    Diagne, Cheikh Tidiane
    Pasi, Omer
    Diop, Boly
    Sall, Amadou A.
    Vigan-Womas, Ines
    Faye, Ousmane
    IJID REGIONS, 2022, 3 : 117 - 125
  • [3] Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study
    Alvarez-Antonio, Carlos
    Meza-Sanchez, Graciela
    Calampa, Carlos
    Casanova, Wilma
    Carey, Cristiam
    Alava, Freddy
    Rodriguez-Ferrucci, Hugo
    Quispe, Antonio M.
    LANCET GLOBAL HEALTH, 2021, 9 (07): : E925 - E931
  • [4] Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study
    Mercado-Reyes, Marcela
    Malagon-Rojas, Jeadran
    Rodriguez-Barraquer, Isabel
    Zapata-Bedoya, Silvana
    Wiesner, Magdalena
    Cucunuba, Zulma
    Guillermo Toloza-Perez, Yesith
    Hernandez-Ortiz, Juan P.
    Acosta-Reyes, Jorge
    Parra-Barrera, Eliana
    Ibanez-Beltran, Edgar
    Quinche, Gianni G.
    Munoz-Galindo, Lyda
    Rubio, Vivian
    Galindo-Borda, Marisol
    Osorio-Velazquez, Erickson G.
    Bermudez-Forero, Andrea
    Pinto-Chacon, Nelson
    Puerto-Castro, Gloria
    Franco-Munoz, Carlos
    Isabel Estupinan, Maria
    Angel Villar, Luis
    Gore-Saravia, Nancy
    Consuelo Miranda-Montoya, Maria
    Castellanos, Jaime
    Margarita Valle, Edna
    Navarro-Lechuga, Edgar
    Daniel Oviedo, Juan
    Ospina-Martinez, Martha
    LANCET REGIONAL HEALTH-AMERICAS, 2022, 9
  • [5] Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study
    Mercado-Reyes, Marcela
    Malagon-Rojas, Jeadran
    Rodriguez-Barraquer, Isabel
    Zapata-Bedoya, Silvana
    Wiesner, Magdalena
    Cucunuba, Zulma
    Toloza-Perez, Yesith Guillermo
    Hernandez-Ortiz, Juan P.
    Acosta-Reyes, Jorge
    Parra-Barrera, Eliana
    Ibanez-Beltran, Edgar
    Quinche, Gianni G.
    Munoz-Galindo, Lyda
    Rubio, Vivian
    Galindo-Borda, Marisol
    Osorio-Velazquez, Erickson G.
    Bermudez-Forero, Andrea
    Pinto-Chacon, Nelson
    Puerto-Castro, Gloria
    Franco-Munoz, Carlos
    Estupinan, Maria Isabel
    Villar, Luis Angel
    Gore-Saravia, Nancy
    Miranda-Montoya, Maria Consuelo
    Castellanos, Jaime
    Valle, Edna Margarita
    Navarro-Lechuga, Edgar
    Oviedo, Juan Daniel
    Martinez, Martha Ospina
    LANCET REGIONAL HEALTH-AMERICAS, 2022, 9
  • [6] Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation
    Martinez-Acuna, Natalia
    Avalos-Nolazco, Diana Minerva
    Rodriguez-Rodriguez, Diana Raquel
    Martinez-Liu, Cynthia Gabriela
    Galan-Huerta, Kame Alberto
    Padilla-Rivas, Gerardo Raymundo
    Ramos-Jimenez, Javier
    Ayala-de-la-Cruz, Sergio
    Cienfuegos-Pecina, Eduardo
    Diaz-Chuc, Erik Alejandro
    Cazares-Tamez, Rogelio
    Flores-Arechiga, Amador
    Perez-Chavez, Fernando
    Arellanos-Soto, Daniel
    Lozano-Sepulveda, Sonia Amelia
    Garza-Gonzalez, Elvira
    Trevino-Garza, Consuelo
    Montes-de-Oca-Luna, Roberto
    Lee-Gonzalez, Aurora Beatriz
    de-la-O-Cavazos, Manuel Enrique
    Rivas-Estilla, Ana Maria
    VIRUSES-BASEL, 2021, 13 (07):
  • [7] Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia
    Adam, Mohamed Hussein
    Mohamoud, Jamal Hasan
    Mohamood, Abdiaziz S.
    Mohamed, Ahmed A.
    Garba, Bashiru
    Dirie, Najib Isse
    VACCINES, 2022, 10 (02)
  • [8] High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
    Naranbhai, Vivek
    Chang, Christina C.
    Beltran, Wilfredo F. Garcia
    Miller, Tyler E.
    Astudillo, Michael G.
    Villalba, Julian A.
    Yang, Diane
    Gelfand, Jeffrey
    Bernstein, Bradley E.
    Feldman, Jared
    Hauser, Blake M.
    Caradonna, Timothy M.
    Alter, Galit
    Murali, Mandakolathur R.
    Jasrasaria, Rashmi
    Quinlan, Joan
    Xerras, Dean C.
    Betancourt, Joseph R.
    Louis, David N.
    Schmidt, Aaron G.
    Lennerz, Jochen
    Poznansky, Mark C.
    Iafrate, A. John
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (12): : 1955 - 1959
  • [9] High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad
    Wondeu, Andrillene Laure Deutou
    Abdelrazakh, Fatima
    Abakar, Mahamat Fayiz
    Yandai, Fissou Henry
    Nodjikouambaye, Aleyo Zita
    Djimtoibaye, Djallaye
    Kimala, Pidou
    Nadjiadjim, Noel
    Naibei, Nathan
    Dzomo, Guy Rodrigue Takoudjou
    Atturo, Sabrina
    Linardos, Giulia
    Russo, Cristina
    Perno, Carlo Federico
    Moussa, Ali Mahamat
    Yokouide, Allarangar
    Tchidjou, Hyppolite Kuekou
    Colizzi, Vittorio
    Choua, Ouchemi
    JOURNAL OF PUBLIC HEALTH IN AFRICA, 2022, 13 (04)
  • [10] Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020
    Flamand, Claude
    Sarmento, Christelle Alves
    Enfissi, Antoine
    Bailly, Sarah
    Beillard, Emmanuel
    Gaillet, Melanie
    Michaud, Celine
    Servas, Veronique
    Clement, Nathalie
    Perilhou, Anais
    Carage, Thierry
    Musso, Didier
    Carod, Jean-Francois
    Eustache, Stephanie
    Tourbillon, Celine
    Boizon, Elodie
    James, Samantha
    Djossou, Felix
    Salje, Henrik
    Cauchemez, Simon
    Rousset, Dominique
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (11):